Mon Naturals working on a Class 1 Medical Device made of hemp polymer to create a plant-based wound dressing.
Tilray will supply a variety of its pharmaceutical-grade medical cannabis products.
Harbour Access has been appointed as North American investor relations advisor to provide support for the listing.
Broughton will be focusing on accelerating products to market within strategic markets including the cannabinoids industry.
Tetra Bio-Pharma’s has received a positive opinion from the EMA’s Committee for Orphan Medicinal Products on its application for Orphan Drug Designation for QIXLEEF.
It is hoped that the changes will move consumers away from the black market.
US cannabis investment company Thought Leaders has acquired UK CBD brand mellow.
Canxchange looks at how COVID-19 has impacted the cannabis market.
MediPharm has announced another GMP cannabis extract delivery to Germany.
Hilltop Leaf CEO says the licence marks a fundamental milestone for the business.